Low- and middle-income populations bear a huge, disproportionate and growing burden of cardiovascular disease which constitutes a threat to development and preventable loss of productive lives.
More that 80% of cardiovascular disease-attributed deaths occur in low- and middle-income populations globally.
The transition in global health from infectious to chronic disease, especially cardiovascular disease, poses a threat to the economies of low- and middle-income populations
To reduce morbidity and mortality related to cardiovascular disease will require training and education and the development of sufficient capacity and infrastructure to carry out population-based approaches for preventing, screening, diagnosis and treating these diseases.
Minority, low- and middle-income populations confront more barriers to cardiovascular disease screening, diagnosis and care, experience worse health outcomes and are faced with more lack of healthcare access to issues globally.
An estimated 17.7 million people died from CVDs in 2017, representing 31% of all global deaths. Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke .
Out of the 17 million premature deaths (under the age of 70) due to noncommunicable diseases in 2017, 82% are in low- and middle-income countries, and 37% are caused by CVDs.
CVD age-adjusted death rates are 33% higher for underserved low- and midle-income communities than for the overall population in the U.S.
American Indians/Alaska Natives die from heart disease much earlier than expected – 36% are under 65 compared with only 17% for the U.S. population overall.
Reports on cardiac care quality of racial/ethnic minority groups found evidence of disparities in 84% of the studies examined.
The number of deaths caused by noncommunicable diseases is expected to increase by 15% by 2020 and the economic burden generated by CVD is estimated to reduce gross GDP by up to 7%.